What the name refers to
A topical finasteride formulation intended to reduce scalp DHT exposure; licensed availability and compounding status vary by market.
Evidence and regulatory context
Medical use or authorisation exists historically or in limited jurisdictions. Current availability, indications and legal classification must be checked against the regulator for the reader’s location.
Reading product records
Route, vehicle and concentration can materially change a topical product. A page about an approved oral or ophthalmic medicine does not automatically validate a compounded hair formulation or an unapproved research product using the same active ingredient.
Primary research links
Use current regulator and study records rather than treating a catalogue description as medical evidence.